Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Competing E3 ubiquitin ligases govern circadian periodicity by degradation of CRY in nucleus and cytoplasm.

Seung-Hee Yoo | Jennifer A Mohawk | Sandra M Siepka | Yongli Shan | Seong Kwon Huh | Hee-Kyung Hong | Izabela Kornblum | Vivek Kumar | Nobuya Koike | Ming Xu | Justin Nussbaum | Xinran Liu | Zheng Chen | Zhijian J Chen | Carla B Green | Joseph S Takahashi
Cell | 2013

Period determination in the mammalian circadian clock involves the turnover rate of the repressors CRY and PER. We show that CRY ubiquitination engages two competing E3 ligase complexes that either lengthen or shorten circadian period in mice. Cloning of a short-period circadian mutant, Past-time, revealed a glycine to glutamate missense mutation in Fbxl21, an F-box protein gene that is a paralog of Fbxl3 that targets the CRY proteins for degradation. While loss of function of FBXL3 leads to period lengthening, mutation of Fbxl21 causes period shortening. FBXL21 forms an SCF E3 ligase complex that slowly degrades CRY in the cytoplasm but antagonizes the stronger E3 ligase activity of FBXL3 in the nucleus. FBXL21 plays a dual role: protecting CRY from FBXL3 degradation in the nucleus and promoting CRY degradation within the cytoplasm. Thus, the balance and cellular compartmentalization of competing E3 ligases for CRY determine circadian period of the clock in mammals.

Pubmed ID: 23452855

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NIMH NIH HHS, United States
    Id: R01 MH078024
  • Agency: NIMH NIH HHS, United States
    Id: U01 MH61915
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM63692
  • Agency: NIDA NIH HHS, United States
    Id: F32 DA024556
  • Agency: NIMH NIH HHS, United States
    Id: U01 MH061915
  • Agency: NIMH NIH HHS, United States
    Id: P50 MH074924
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM090247
  • Agency: Howard Hughes Medical Institute, United States

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Applied Biosystems (tool)

RRID:SCR_005039

An Antibody supplier

View all literature mentions

New England Biolabs (tool)

RRID:SCR_013517

An Antibody supplier

View all literature mentions